Cargando…

Targeting Chronic Myeloid Leukemia Stem/Progenitor Cells Using Venetoclax-Loaded Immunoliposome

SIMPLE SUMMARY: Chronic myeloid leukemia stem cells (CML LSCs) are a rare and quiescent population that are resistant to tyrosine kinase inhibitors. CML LSCs have many features in common with hematopoietic stem cells (HSCs) and selectively targeting this population and sparing HSCs is of paramount i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Houshmand, Mohammad, Garello, Francesca, Stefania, Rachele, Gaidano, Valentina, Cignetti, Alessandro, Spinelli, Michela, Fava, Carmen, Nikougoftar Zarif, Mahin, Galimberti, Sara, Pungolino, Ester, Annunziata, Mario, Luciano, Luigia, Specchia, Giorgina, Bocchia, Monica, Binotto, Gianni, Bonifacio, Massimiliano, Martino, Bruno, Pregno, Patrizia, Stagno, Fabio, Iurlo, Alessandra, Russo, Sabina, Aime, Silvio, Circosta, Paola, Saglio, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000981/ https://www.ncbi.nlm.nih.gov/pubmed/33804056 http://dx.doi.org/10.3390/cancers13061311

Ejemplares similares

Bone marrow microenvironment: The guardian of leukemia stem cells
por: Houshmand, Mohammad, et al.
Publicado: (2019)

Current Strategies and Future Directions to Achieve Deep Molecular Response and Treatment-Free Remission in Chronic Myeloid Leukemia
por: Annunziata, Mario, et al.
Publicado: (2020)

Shedding Light on Targeting Chronic Myeloid Leukemia Stem Cells
por: Houshmand, Mohammad, et al.
Publicado: (2021)

Chronic myeloid leukemia stem cells
por: Houshmand, Mohammad, et al.
Publicado: (2019)

Next-generation sequencing for BCR-ABL1 kinase domain mutation testing in patients with chronic myeloid leukemia: a position paper
por: Soverini, Simona, et al.
Publicado: (2019)

Chronic myeloid leukemia management at the time of the COVID-19 pandemic in Italy. A campus CML survey
por: Breccia, Massimo, et al.
Publicado: (2020)

Nanocarriers as Magic Bullets in the Treatment of Leukemia
por: Houshmand, Mohammad, et al.
Publicado: (2020)

Inhibition of bromodomain and extra‐terminal proteins increases sensitivity to venetoclax in chronic lymphocytic leukaemia
por: Carrà, Giovanna, et al.
Publicado: (2019)

Long noncoding RNA PVT1: potential oncogene in the development of acute lymphoblastic leukemia
por: YAZDI, Narjes, et al.
Publicado: (2018)

MicroRNA Microarray Profiling during Megakaryocyte Differentiation of Cord Blood CD133+ Hematopoietic Stem Cells
por: Houshmand, Mohammad, et al.
Publicado: (2018)

Treatment-Free Remission in Chronic Myeloid Leukemia Patients Treated With Low-Dose TKIs: A Feasible Option Also in the Real-Life. A Campus CML Study
por: Iurlo, Alessandra, et al.
Publicado: (2022)

Dihydroorotate dehydrogenase inhibition reveals metabolic vulnerability in chronic myeloid leukemia
por: Houshmand, Mohammad, et al.
Publicado: (2022)

The Synergism between DHODH Inhibitors and Dipyridamole Leads to Metabolic Lethality in Acute Myeloid Leukemia
por: Gaidano, Valentina, et al.
Publicado: (2021)

The Important Role of FLT3-L in Ex Vivo Expansion of Hematopoietic Stem Cells following Co-Culture with Mesenchymal Stem Cells
por: Oubari, Farhad, et al.
Publicado: (2015)

Irradiation enhances susceptibility of tumor cells to the antitumor effects of TNF-α activated adipose derived mesenchymal stem cells in breast cancer model
por: Mohammadpour, Hemn, et al.
Publicado: (2016)

Treatment discontinuation following low-dose TKIs in 248 chronic myeloid leukemia patients: Updated results from a campus CML real-life study
por: Iurlo, A., et al.
Publicado: (2023)

Observational study of chronic myeloid leukemia Italian patients who discontinued tyrosine kinase inhibitors in clinical practice
por: Fava, Carmen, et al.
Publicado: (2019)

Frontline Dasatinib Treatment in a “Real-Life” Cohort of Patients Older than 65 Years with Chronic Myeloid Leukemia
por: Latagliata, Roberto, et al.
Publicado: (2016)

The Effect of Mir-451 Upregulation on Erythroid Lineage Differentiation of Murine Embryonic Stem Cells
por: Obeidi, Narges, et al.
Publicado: (2016)

The potential effect of leukocyte filtration methods on erythrocyte-derived microvesicles: One step forward
por: Roshanzamir, Fateme, et al.
Publicado: (2022)

Targeting immunoliposomes to EGFR-positive glioblastoma
por: Kasenda, B., et al.
Publicado: (2022)

The High Yield Expansion and Megakaryocytic Differentiation of Human Umbilical Cord Blood CD133(+) Cells
por: Nikougoftar Zarif, Mahin, et al.
Publicado: (2011)

Association between cytokines and two circulating micro-RNAs and development of premature ventricular contractions-induced cardiomyopathy
por: Ghadrdoost, Behshid, et al.
Publicado: (2019)

Effects of Quercetin Supplementation on Hematological Parameters in Non-Alcoholic Fatty Liver Disease: a Randomized, Double-Blind, Placebo-Controlled Pilot Study
por: Pasdar, Yahya, et al.
Publicado: (2020)

Prognostic Factors for Overall Survival In Chronic Myeloid Leukemia Patients: A Multicentric Cohort Study by the Italian CML GIMEMA Network
por: Specchia, Giorgina, et al.
Publicado: (2021)

Incidence of second primary malignancies and related mortality in patients with imatinib-treated chronic myeloid leukemia
por: Gugliotta, Gabriele, et al.
Publicado: (2017)

Immunoliposomes for detection of rupture-prone intracranial aneurysms
por: Jahromi, Behnam Rezai, et al.
Publicado: (2023)

Arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real‐life practice are predicted by the Systematic Coronary Risk Evaluation (SCORE) chart
por: Caocci, Giovanni, et al.
Publicado: (2019)

A Clinically Applicable Approach to the Classification of B-Cell Non-Hodgkin Lymphomas with Flow Cytometry and Machine Learning
por: Gaidano, Valentina, et al.
Publicado: (2020)

Immunoliposomes doubly targeted to transferrin receptor and to α-synuclein
por: Loureiro, Joana A, et al.
Publicado: (2015)

Imatinib and polypharmacy in very old patients with chronic myeloid leukemia: effects on response rate, toxicity and outcome
por: Iurlo, Alessandra, et al.
Publicado: (2016)

Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5-a]pyridine Scaffold: SAR of the Biphenyl Moiety
por: Sainas, Stefano, et al.
Publicado: (2021)

Efficacy and safety of nilotinib as frontline treatment in elderly (> 65 years) chronic myeloid leukemia patients outside clinical trials
por: Luciano, Luigia, et al.
Publicado: (2023)

P667: RISK OF PROGRESSION IN CHRONIC PHASE-CHRONIC MYELOID LEUKEMIA PATIENTS ELIGIBLE FOR TYROSINE KINASE INHIBITOR DISCONTINUATION: FINAL ANALYSIS OF THE TFR-PRO STUDY
por: Paolo Maria Zambrotta, Giovanni, et al.
Publicado: (2023)

Characterization of highly stable liposomal and immunoliposomal formulations of vincristine and vinblastine
por: Noble, Charles O., et al.
Publicado: (2009)

Immunoliposome-based fluorometric patulin assay by using immunomagnetic nanoparticles
por: Song, Xinjie, et al.
Publicado: (2019)

Simultaneous regulation of miR-451 and miR-191 led to erythroid fate decision of mouse embryonic stem cell
por: Shokri, Gelareh, et al.
Publicado: (2019)

Immunoliposome-mediated targeting of doxorubicin to human ovarian carcinoma in vitro and in vivo.
por: Vingerhoeds, M. H., et al.
Publicado: (1996)

Study of the efficacy of antimalarial drugs delivered inside targeted immunoliposomal nanovectors
por: Urbán, Patricia, et al.
Publicado: (2011)

Proof-of-concept in vivo evaluation of targeted therapeutics: lessons from immunoliposomes
por: Benz, CC
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_0gjk1p8u0o3jvf1fou2r17ump2